Results 261 to 270 of about 1,327,671 (358)
Objective To evaluate the efficacy and safety of baricitinib in pediatric patients with active juvenile idiopathic arthritis–associated uveitis (JIA‐U) or chronic anterior antinuclear antibody–positive uveitis, who had an inadequate response to methotrexate (MTX) or biologic disease‐modifying antirheumatic drugs (bDMARDs).
Athimalaipet V. Ramanan +7 more
wiley +1 more source
The significance of green innovation efficiency of green low-carbon circular economy for sustainable cities in western China-Empirical evidence from Chongqing municipality. [PDF]
Li P.
europepmc +1 more source
Objective Foot orthoses are thought to improve pain by potentially modifying internal mechanical forces. To test this, we explored whether foot orthoses can modify patterns of bone marrow lesions (BMLs) in people with midfoot pain. Methods Forty‐two people were recruited with midfoot pain, and magnetic resonance imaging–confirmed midfoot BMLs ...
Jill Halstead +4 more
wiley +1 more source
Can green location-oriented policies promote substantive green innovation by enterprises? Evidence from China's National Eco-Industrial Demonstration Parks. [PDF]
Tian J, Qiu W.
europepmc +1 more source
Leveraging digital alliances for green innovations: a pathway to becoming green
David Bendig +3 more
openalex +1 more source
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multidisciplinary team‐based care.
Tarun Sharma +7 more
wiley +1 more source
ESG performance and green innovation in commercial banks: Evidence from China. [PDF]
Wang Q, Zhang Y, Li Y, Wang P.
europepmc +1 more source
The Role of Green Innovation, Renewable Energy, and Institutional Quality in Promoting Green Growth: Evidence from African Countries [PDF]
Derese Kebede Teklie, Mete Han Yağmur
openalex +1 more source
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal
Adam S. Mayer +5 more
wiley +1 more source

